J. Goldman & Co’s Terns Pharmaceuticals TERN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-67,500	Closed	-$186K	–	476
2025 Q1	$186K	Sell	67,500 -168,331	-71%	-$465K	﹤0.01%	288
2024 Q4	$1.31M	Buy	235,831 +31,890	+16%	+$177K	0.03%	223
2024 Q3	$1.7M	Buy	+203,941	New	+$1.7M	0.05%	166